F32
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: At least moderate depressive episode (clinical diagnosis according to ICD-10); depressiveness measured with the PHQ-8 = 10, age >=18 years, very good knowledge of German; patients for whom new antidepressants are prescribed at the start of treatment, or the antidepressant medication is changed (dose, preparation).
Exclusion criteria
Exclusion criteria: Excluded from the study are patients who are being treated with a placement request, patients on protected wards, patients with acute psychotic symptoms (delusional symptoms or hallucinations described in the AMDP findings), a currently existing addiction disorder, persons who were admitted to the hospital during their stay: patients with acute psychotic symptoms (delusional symptoms or hallucinations described in the AMDP findings), a current addiction disorder, persons who are prescribed benzodiazepines during their inpatient stay (except for medication on demand); no cognitive-mnestic deficits relevant to everyday life, in particular no cognitive deficits that make it impossible for patients to complete the questionnaires independently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Change in expectations, measured with the Treatment Expectation Questionnaire (Alberts et al., 2020) - Change in depressive symptoms measured with the PHQ-8 (Kroenke et al., 2009) - Change in side effects of medication with the Generic Assessment of Side Effects Scale (GASE; Rief et al., 2011) | — |
Secondary
| Measure | Time frame |
|---|---|
| Practitioner-patient relationship; shared decision making | — |
Countries
Germany
Contacts
HMU Health and Medical University Potsdam